1.Photodynamic Therapy for Unresectable Cholangiocarcinoma:Does It Really Increase the Survival Time?.
Eun Kwang CHOI ; Myung Hwan KIM
The Korean Journal of Gastroenterology 2005;45(6):446-446
No abstract available
Bile Duct Neoplasms/*drug therapy/mortality
;
*Bile Ducts, Intrahepatic
;
Cholangiocarcinoma/*drug therapy/mortality
;
Humans
;
*Photochemotherapy
;
Survival Rate
2.Long-Term Outcome of Photodynamic Therapy with Systemic Chemotherapy Compared to Photodynamic Therapy Alone in Patients with Advanced Hilar Cholangiocarcinoma.
Mi Jin HONG ; Young Koog CHEON ; Eung Jun LEE ; Tae Yoon LEE ; Chan Sup SHIM
Gut and Liver 2014;8(3):318-323
BACKGROUND/AIMS: Patients with cholangiocarcinoma usually present at an advanced stage, and more than 50% of cases are not resectable at the time of diagnosis. Recently, photodynamic therapy (PDT) has been proposed as a palliative and neoadjuvant modality. We evaluated whether combination of PDT and chemotherapy is more effective than PDT alone. METHODS: In total, 161 patients with cholangiocarcinoma diagnosed between February 1999 and September 2009 were evaluated. Sixteen patients were treated with PDT and chemotherapy (group A), and 58 were treated with PDT (group B). RESULTS: The median survival was 538 days (95% confidence interval [CI], 475.3 to 600.7) in group A and 334 days (95% CI, 252.5 to 415.5) in group B (p=0.05). Lymph node metastasis status, serum bilirubin of pretreatment, tumor node metastasis stage, treatment method (PDT with chemotherapy vs PDT alone), time to PDT and the number of PDT sessions were prognostic factors with statistical significance in the univariate analysis. A multivariate analysis showed that PDT with chemotherapy and more than two sessions of PDT were significant independent predictors of longer survival in advanced cholangiocarcinoma (hazard ratio [HR], 2.23; 95% CI, 1.18 to 4.20; p=0.013 vs HR, 1.79; 95% CI, 1.044 to 3.083; p=0.034). CONCLUSIONS: PDT with chemotherapy results in longer survival than PDT alone.
Adult
;
Aged
;
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
;
Bile Duct Neoplasms/*drug therapy
;
*Bile Ducts, Intrahepatic
;
Cholangiocarcinoma/*drug therapy/mortality
;
Cholangiopancreatography, Endoscopic Retrograde
;
Cisplatin/administration & dosage
;
Combined Modality Therapy/mortality
;
Deoxycytidine/administration & dosage/analogs & derivatives
;
Female
;
Fluorouracil/administration & dosage
;
Humans
;
Kaplan-Meier Estimate
;
Male
;
Middle Aged
;
Photochemotherapy/*methods/mortality
;
Treatment Outcome